Equities

Fortrea Holdings Inc

Fortrea Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)23.86
  • Today's Change0.88 / 3.83%
  • Shares traded2.00
  • 1 Year change-15.69%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments10911295
Total Receivables, Net9891,022927
Total Inventory------
Prepaid expenses8511396
Other current assets, total69----
Total current assets1,2511,2471,118
Property, plant & equipment, net173165163
Goodwill, net1,7391,9972,081
Intangibles, net728823936
Long term investments------
Note receivable - long term------
Other long term assets705471
Total assets4,3334,2884,369
LIABILITIES
Accounts payable1338261
Accrued expenses353319429
Notes payable/short-term debt000
Current portion long-term debt/capital leases26----
Other current liabilities, total267299337
Total current liabilities778699827
Total long term debt1,56600
Total debt1,59200
Deferred income tax148185210
Minority interest------
Other liabilities, total1276271
Total liabilities2,6199451,108
SHAREHOLDERS EQUITY
Common stock0.10----
Additional paid-in capital1,998----
Retained earnings (accumulated deficit)(69)----
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(216)3,3433,261
Total equity1,7143,3433,261
Total liabilities & shareholders' equity4,3334,2884,369
Total common shares outstanding898989
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.